Johnson & Johnson reported $11.68B in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US USD 4.93B 173M
Becton, Dickinson and BDX:US USD 3.6B 380M
Biogen BIIB:US USD 1.34B 30.6M
Cardiovascular Systems CSII:US USD 41.19M 3.25M
Dexcom DXCM:US USD 306.7M 4.3M
Edwards Lifesciences EW:US USD 875.5M 117.7M
Gilead Sciences GILD:US USD 2.82B 218M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Globus Medical GMED:US USD 298.98M 16.57M
Hologic HOLX:US USD 677.7M 54M
Insulet PODD:US USD 346.8M 19.2M
Integra Lifesciences IART:US USD 324.58M 13.52M
Intuitive Surgical ISRG:US USD 893.2M 56.1M
Medtronic MDT:US USD 5.38B 320M
Merit Medical Systems MMSI:US USD 265.99M 19.33M
Novartis NOVN:VX USD 7.18B 396M
Nuvasive NUVA:US USD 338.6M 2.39M
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Roche Holding ROG:VX 8.6B 313M
Stryker SYK:US USD 4B 112M
Tandem Diabetes Care TNDM:US USD 111.12M 6.34M
Teva Pharmaceutical TEVA:IT USD 3.83B 26M
Vertex Pharmaceuticals VRTX:US USD 460.6M 72.4M
Zimmer Biomet Holdings Inc ZBH:US USD 2.15B 18.6M
Zoetis ZTS:US USD 2.35B 42M